ALDARA

This brand name is authorized in United States. It is also authorized in Australia, Austria, Canada, Croatia, Cyprus, Ecuador, Estonia, Finland, France, Hong Kong SAR China, Ireland, Israel, Italy, Lithuania, Mexico, Netherlands, Poland, Romania, Singapore, South Africa, Spain, Tunisia, Turkey, UK.

Active ingredients

The drug ALDARA contains one active pharmaceutical ingredient (API):

1	Imiquimod UNII P1QW714R7M - IMIQUIMOD
	Imiquimod is an immune response modifier. Saturable binding studies suggest a membrane receptor for imiquimod exists on responding immune cells. Imiquimod has no direct antiviral activity.
	Read more about Imiquimod

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
ALDARA Cream	MPI, EU: SmPC	European Medicines Agency (EU)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
D06BB10	Imiquimod	D Dermatologicals → D06 Antibiotics and chemotherapeutics for dermatological use → D06B Chemotherapeutics for topical use → D06BB Antivirals
Discover more medicines within D06BB10

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
AU	Pharmaceutical Benefits Scheme	10106X, 2546B, 2637T, 4134N, 4559Y
CA	Health Products and Food Branch	02239505
EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	2487-MEE-0916, 3022-MEE-0917
EE	Ravimiamet	1060322, 1471306
ES	Centro de información online de medicamentos de la AEMPS	98080001
FI	Lääkealan turvallisuus- ja kehittämiskeskus	452862
FR	Base de données publique des médicaments	66916232
GB	Medicines & Healthcare Products Regulatory Agency	138260, 161365, 178955, 40227
HK	Department of Health Drug Office	44090
IE	Health Products Regulatory Authority	11014, 11138, 11181, 11601, 11619, 11635
IL	מִשְׂרַד הַבְּרִיאוּת	4005
IT	Agenzia del Farmaco	034405011
LT	Valstybinė vaistų kontrolės tarnyba	1027347, 1063631
MX	Comisión Federal para la Protección contra Riesgos Sanitarios	524M98
NL	Z-Index G-Standaard	14331969
NL	Z-Index G-Standaard, PRK	55050
PL	Rejestru Produktów Leczniczych	100094245
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W69278001
SG	Health Sciences Authority	10105P
TN	Direction de la Pharmacie et du Médicament	23763011
TR	İlaç ve Tıbbi Cihaz Kurumu	8698856350091, 8698856350435, 8698856350633
US	FDA, National Drug Code	99207-260
ZA	Health Products Regulatory Authority	32/34/0541